Home
Open Orphan

Open Orphan Market Share Analysis for May 2026

The world's leading human challenge trial CRO. Specialist laboratory services in virology, immunology & bioanalysis. UK-based, globally operating.

Industry: N/A

Domainopenorphan.com

Year Founded2017

Employees51 - 200

Annual Revenue$25M - $50M

Open Orphan

Open Orphan (including company regionals)

openorphan.com

See more website traffic and engagement information

Open Orphan Revenue up to May 2026 is 25M - 50M

revenue generated by Open Orphan top domains

Open Orphan top domains revenue over 3 years

Revenue for Open Orphan top domains

openorphan.com25M - 50M

See more with Sales Intelligence

Total visits to Open Orphan's top domains

Understand Open Orphan market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Open Orphan's top domains

Analyze Open Orphan engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Open Orphan's top domains

See how Open Orphan keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Open Orphan top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Open Orphan

These are the website technologies, by industry, used by Open Orphan top domains

Social (3)

Instagram

Payment & Currencies (2)

Euro

Advertising (1)

Awin

Audio Video Media (1)

YouTube

More Technologies

6

See all

News & Signals from Open Orphan

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOpenorphan hired Stephen Pinkerton as chief financial officer on Dec 31st '22.Dublin-listed pharmaceutical services company Open Orphan has announced the appointment of Stephen Pinkerton as chief financial officer and as an executive director with immediate effect.

NewsOpenorphan hired Martin Gouldstone as Independent Non-Executive Director on Jun 8th '22.Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces the appointment of Martin Gouldstone as an Independent Non-Executive Director of the Company with effect from 8 June 2022.

NewsOpenorphan hired Yamin 'Mo' Khan as Chief Executive Officer on Feb 24th '22.Specialist pharmaceutical services clinical research company Open Orphan has appointed Yamin 'Mo' Khan as its chief executive with immediate effect.